Celldex Therapeutics buy Cantor Fitzgerald
Start price
22.03.24
/
50%
€38.80
Target price
22.03.25
€61.99
Performance (%)
-10.82%
Price
15:41
€34.60
Summary
This prediction is currently active. The prediction for Celldex Therapeutics disappoints with a performance of -10.82%. This prediction currently runs until 22.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | 15.385% | 15.385% |
iShares Core DAX® | -0.598% | 0.645% |
iShares Nasdaq 100 | -3.290% | -4.193% |
iShares Nikkei 225® | -0.796% | -0.582% |
iShares S&P 500 | -1.164% | -0.857% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $67.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.80
03.11.23
03.11.23
€48.43
03.11.24
03.11.24
45.38%
15:41
15:41
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.00
12.10.23
12.10.23
€51.15
12.10.24
12.10.24
64.00%
15:41
15:41
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.80
27.09.23
27.09.23
€51.25
27.09.24
27.09.24
58.91%
15:41
15:41
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.80
16.08.23
16.08.23
€49.46
16.08.24
16.08.24
24.46%
15:41
15:41